Late Stage Development

Innovative tools like the fully validated AMS   BYOD-type Patient Reported Outcome solution (AMS  ePro) will help to save money and time, e.g. with Patient Diaries and Quality of Life Questionnaires.

AMS  has extensive experience in Late-phase studies (Phases IIIb and IV) and is prepared for the quite new concept of low-interventional studies. The challenge of high-quality data while meeting all requirements, tight timelines and a limited budget, remains in Non-interventional studies (NIS).

In a non-interventional study, you may want to evaluate a real-life patient population and include a large number of investigators and institutions – AMS  processes ensure a smooth handling of all study activities.

Although your project plan is easy, compliance may be problematic. AMS  staff are aware of regulatory and data protection requirements and assure compliance during the course of your study.

 

Read more or find out how AMS  Clinical Research services can meet your needs:

Get in touch with us at:

• 2021 – New Literature Search tool launched • 2021 – DIGA dossier submission pioneer • 2021 – NIS-eTMF launched • 2021 – MDR readiness, AMS prepared for Medical Device Trials under new regulation • 2021 – VO (EU) 536/2014, AMS among the first 100 participants in the EMA CTIS Trainer Programme • 2021 – eSignature, AMS introduced DocuSign® • 2017 – Globally unique AMS-ePRO® features • 2016 – CRO of the year award •

News